Exploring Sirtuins: New Frontiers in Managing Heart Failure with Preserved Ejection Fraction

Abstract

With increasing research, the sirtuin (SIRT) protein family has become increasingly understood. Studies have demonstrated that SIRTs can aid in metabolism and affect various physiological processes, such as atherosclerosis, heart failure (HF), hypertension, type 2 diabetes, and other related disorders. Although the pathogenesis of HF with preserved ejection fraction (HFpEF) has not yet been clarified, SIRTs have a role in its development. Therefore, SIRTs may offer a fresh approach to the diagnosis, treatment, and prevention of HFpEF as a novel therapeutic intervention target.

Keywords

• SIRTs
• heart failure
• heart failure with preserved ejection fraction
• left ventricular diastolic dysfunction
• development
• treatment